Cargando…
CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma
BACKGROUND: The development of drug resistance leads many NPC patients to experience disease relapse following the completion of chemotherapy. It is thus essential that the mechanistic basis for such chemoresistance be clarified in an effort to identify approaches to sensitizing NPC tumors to treatm...
Autores principales: | Lin, Junwu, Qin, Hong, Han, Yue, Li, Xinghua, Zhao, YuJuan, Zhai, Guangsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850406/ https://www.ncbi.nlm.nih.gov/pubmed/33536745 http://dx.doi.org/10.2147/DDDT.S292180 |
Ejemplares similares
-
Knockdown of circNRIP1 sensitizes colorectal cancer to 5-FU via sponging miR-532-3p
por: Liu, Fanfan, et al.
Publicado: (2021) -
Emerging roles of circ_NRIP1 in tumor development and cancer therapy (Review)
por: Gao, Xin, et al.
Publicado: (2023) -
Downregulation of circNRIP1 Suppresses the Paclitaxel Resistance of Ovarian Cancer via Regulating the miR-211-5p/HOXC8 Axis
por: Li, Meng, et al.
Publicado: (2020) -
CircNRIP1 Exerts Oncogenic Functions in Papillary Thyroid Carcinoma by Sponging miR-653-5p and Regulating PBX3 Expression
por: Fu, Lijun, et al.
Publicado: (2022) -
Down-Regulation of circNRIP1 Promotes the Apoptosis and Inhibits the Migration and Invasion of Gastric Cancer Cells by miR-182/ROCK1 Axis
por: Liang, Lu, et al.
Publicado: (2020)